SEC Form 4 · accession 0000899243-19-006332
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey W Dr Guy
Officer — Executive Chairman · Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 9:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Mar 1, 2019 | M | 7 | $0.0013 | A | 8,465,528 | D | |
| Ordinary SharesF1,F2 | Mar 1, 2019 | M | 15,336 | $0.0013 | A | 8,480,864 | D | |
| Ordinary SharesF1,F2 | Mar 1, 2019 | M | 25,914 | $0.0013 | A | 8,506,778 | D | |
| Ordinary SharesF1,F2 | Mar 1, 2019 | M | 345,517 | $0.0013 | A | 8,852,295 | D | |
| Ordinary SharesF1,F2 | Mar 1, 2019 | M | 182,171 | $3.3924 | A | 9,034,466 | D | |
| Ordinary SharesF1,F2 | Mar 1, 2019 | M | 7,055 | $0.0013 | A | 9,041,521 | D | |
| Ordinary SharesF3,F4 | Mar 1, 2019 | S | 300,000 | $14.49 | D | 103,925 | I | By personal pension plan |
| Ordinary SharesF5,F4 | Mar 4, 2019 | S | 900,000 | $14.75 | D | 8,141,521 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $0.0013 | Mar 1, 2019 | M | 7 | D | Feb 15, 2018 | Feb 15, 2026 | Ordinary Shares | 7 | 0 | D |
| Stock OptionsF2 | $0.0013 | Mar 1, 2019 | M | 15,336 | D | Aug 10, 2018 | Aug 10, 2027 | Ordinary Shares | 15,336 | 0 | D |
| Stock OptionsF2 | $0.0013 | Mar 1, 2019 | M | 25,914 | D | Feb 15, 2019 | Feb 15, 2026 | Ordinary Shares | 25,914 | 0 | D |
| Stock OptionsF2 | $0.0013 | Mar 1, 2019 | M | 345,517 | D | Feb 15, 2019 | Feb 15, 2026 | Ordinary Shares | 345,517 | 0 | D |
| Stock OptionsF2 | $3.3924 | Mar 1, 2019 | M | 182,171 | D | Feb 15, 2019 | Feb 15, 2026 | Ordinary Shares | 182,171 | 0 | D |
| Stock OptionsF2 | $0.0013 | Mar 1, 2019 | M | 7,055 | D | Feb 26, 2019 | Feb 26, 2028 | Ordinary Shares | 7,055 | 9,262 | D |
| Stock OptionsF6,F7,F8 | $14.33 | Mar 1, 2019 | A | 75,252 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 75,252 | 75,252 | D |
| Stock OptionsF6,F2 | $0.0013 | Mar 1, 2019 | A | 142,824 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 142,824 | 142,824 | D |
| Stock OptionsF6,F2 | $0.0013 | Mar 1, 2019 | A | 10,704 | A | Mar 1, 2020 | Mar 1, 2029 | Ordinary Shares | 10,704 | 10,704 | D |
| Stock OptionsF6,F2 | $0.0013 | Mar 1, 2019 | A | 10,704 | A | Mar 1, 2021 | Mar 1, 2029 | Ordinary Shares | 10,704 | 10,704 | D |
| Stock OptionsF6,F2 | $0.0013 | Mar 1, 2019 | A | 10,704 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 10,704 | 10,704 | D |
| Stock OptionsF6,F2 | $0.0013 | Mar 1, 2019 | A | 10,704 | A | Mar 1, 2023 | Mar 1, 2029 | Ordinary Shares | 10,704 | 10,704 | D |
Explanation of responses
- F1Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.
- F3The 300,000 ordinary shares sold pursuant to the reported transaction are represented by ADSs. Following the reported transaction, 103,920 shares of the remaining shares are represented by ADSs.
- F4The price reported in Column 4 is price per ordinary share converted from price per ADS.
- F5Represented by ADSs.
- F6Granted pursuant to the Issuer's Long-Term Incentive Plan
- F7The reported options are options to purchase ADSs.
- F8The exercise price reported is price per ordinary share converted from price per ADS ($172.01).